These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 34309066)
1. Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. Montal V; Barroeta I; Bejanin A; Pegueroles J; Carmona-Iragui M; Altuna M; Benejam B; Videla L; Fernández S; Padilla C; Aranha MR; Iulita MF; Vidal-Piñeiro D; Alcolea D; Blesa R; Lleó A; Fortea J; Ann Neurol; 2021 Sep; 90(3):407-416. PubMed ID: 34309066 [TBL] [Abstract][Full Text] [Related]
2. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea J; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernández S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Alcolea D; Clarimón J; Zaman SH; Blesa R; Lleó A Lancet; 2020 Jun; 395(10242):1988-1997. PubMed ID: 32593336 [TBL] [Abstract][Full Text] [Related]
3. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624 [TBL] [Abstract][Full Text] [Related]
4. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study. Schott JM; Frost C; MacManus DG; Ibrahim F; Waldman AD; Fox NC Brain; 2010 Nov; 133(11):3315-22. PubMed ID: 20739347 [TBL] [Abstract][Full Text] [Related]
5. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400 [TBL] [Abstract][Full Text] [Related]
7. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study. Waragai M; Moriya M; Nojo T J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236 [TBL] [Abstract][Full Text] [Related]
11. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028 [TBL] [Abstract][Full Text] [Related]
12. Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease. Benejam B; Aranha MR; Videla L; Padilla C; Valldeneu S; Fernández S; Altuna M; Carmona-Iragui M; Barroeta I; Iulita MF; Montal V; Pegueroles J; Bejanin A; Giménez S; González-Ortiz S; Videla S; Bartrés-Faz D; Alcolea D; Blesa R; Lleó A; Fortea J Alzheimers Res Ther; 2022 Sep; 14(1):123. PubMed ID: 36057615 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. Carmona-Iragui M; Alcolea D; Barroeta I; Videla L; Muñoz L; Van Pelt KL; Schmitt FA; Lightner DD; Koehl LM; Jicha G; Sacco S; Mircher C; Pape SE; Hithersay R; Clare ICH; Holland AJ; Nübling G; Levin J; Zaman SH; Strydom A; Rebillat AS; Head E; Blesa R; Lleó A; Fortea J Lancet Neurol; 2021 Aug; 20(8):605-614. PubMed ID: 34302785 [TBL] [Abstract][Full Text] [Related]
14. Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome. Rafii MS Dev Neurobiol; 2019 Jul; 79(7):711-715. PubMed ID: 30536948 [TBL] [Abstract][Full Text] [Related]
16. Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). Rafii MS; Donohue MC; Matthews DC; Muranevici G; Ness S; O'Bryant SE; Rissman RA J Alzheimers Dis; 2019; 70(1):131-138. PubMed ID: 31156181 [TBL] [Abstract][Full Text] [Related]
17. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW; Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191 [TBL] [Abstract][Full Text] [Related]
18. Neurometabolite mapping highlights elevated myo-inositol profiles within the developing brain in down syndrome. Patkee PA; Baburamani AA; Long KR; Dimitrova R; Ciarrusta J; Allsop J; Hughes E; Kangas J; McAlonan GM; Rutherford MA; De Vita E Neurobiol Dis; 2021 Jun; 153():105316. PubMed ID: 33711492 [TBL] [Abstract][Full Text] [Related]
19. Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults. Hone-Blanchet A; Bohsali A; Krishnamurthy LC; Shahid S; Lin Q; Zhao L; Loring D; Goldstein F; John SE; Fleischer CC; Levey A; Lah J; Qiu D; Crosson B Neurobiol Aging; 2022 Jan; 109():22-30. PubMed ID: 34638000 [TBL] [Abstract][Full Text] [Related]
20. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Forester BP; Finn CT; Berlow YA; Wardrop M; Renshaw PF; Moore CM Bipolar Disord; 2008 Sep; 10(6):691-700. PubMed ID: 18837863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]